M2Bio Sciences (OTC: $WUHN) Launches Mental Illness Drug Discovery Company Neurai Life Sciences.
Ryan Allway January 19th, 2022 CAPE TOWN, SA / ACCESSWIRE / January 19, 2022 / WUHAN GENERAL GROUP, INC. (OTC PINK:WUHN) (“WGG” or the “Company”), a bioceutical company focused on alternative plant-based cannabinoids and mental health therapeutic research is pleased to share the following update: Wuhan General Group, Inc./M2Bio Sciences,... Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )